11/01/2017 21:27:11

SHAREHOLDER COMPLAINT: Levi & Korsinsky, LLP Files in U.S. District Court to Recover Losses Suffered by Investors in Ophthotech Corporation – Sets Lead Plaintiff Deadline of March 13, 2017

NEW YORK, Jan. 11, 2017 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired shares of Ophthotech Corporation (“Ophthotech”) (NASDAQ:OPHT) between May 11, 2015 and December 12, 2016. You are hereby notified that Levi & Korsinsky has commenced the class action Micholle v. Ophthotech Corporation, et al.(Case No. 1:17-cv-00210) in the USDC for the Southern District of New York. To get more information go to:

http://zlk.9nl.com/ophthotech

or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that, throughout the Class Period, Ophthotech made overtly positive representations about the effectiveness and potential of its treatment Fovista when used in combination with Lucentis, a commercially available anti-vascular endothelial growth factor agent, despite awareness that the phase 3 clinical trial of Fovista would fail to achieve its primary endpoint of change in best corrected visual acuity from baseline at 12 months over Lucentis alone. The complaint further alleges that these statements caused Ophthotech stock to trade at artificially inflated prices.

On December 12, 2016, Ophthotech announced that the trial had failed to achieve its primary endpoint, and that Fovista and Lucentis demonstrated a non-statically significant improvement over patients only receiving Lucentis. Following this news, shares of Ophthotech fell approximately 86% to close at $5.29.

Take Action: if you suffered a loss in Ophthotech you have until March 13, 2017to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

30 Broad Street - 24th Floor

New York, NY 10004

Tel: (212) 363-7500

Toll Free: (877) 363-5972

Fax: (212) 363-7171

www.zlk.com

Primary Logo

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
27 May
PNDORA
Normal 0 21 false false false DA X-NONE X-NONE ..
46
23 May
 
For nogle af mine kunder, laver jeg en kvartals-analyse over, hvordan de Nordiske selskabers indtjen..
25
28 May
PNDORA
Alle disse Pandora tråde vidner i høj grad om desperation.
24
27 May
PNDORA
Jeg læser i indlæggene om Pandora, da jeg selv er investeret i den aktie, og specielt i tråd nr. 390..
14
25 May
PNDORA
Tjah det er altid svaert for en amatoer som mig at vide hvornaar er det rigtige tidspunkt at koebe e..
14
24 May
PNDORA
Nej for det er Breaking news.
12
23 May
 
Man korser sig når man ser hvad nogle mennesker kan finde på og skrive, blot fordi de kan gøre det a..
12
23 May
 
Hold øje med at politikere og andre nu som sædvanligt vil mane os til "at stå sammen" og "ikke lade ..
12
25 May
ZEAL
-Jeg mindes ikke at handlet med en aktie som deler vandene så meget som Zealand Pharma. Jeg har vær..
11
23 May
 
Hellere en nytteløs klovn end en svinsk og ubehagelig klovn som dig. Mage til ubehagelig optræden.
11

Form 8.3 - AXA INVESTMENT MANAGERS : Berendsen Plc

29/05/2017 14:25:13
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: AXA Investment Managers (b) Owner o..

Astana International Financial Centre JSC and Nasdaq Sign Technology Deal for New AIFC Exchange

29/05/2017 08:00:13
The  AIFC Exchange  will run on Nasdaq Financial Framework trading technology  The new exchange is targeted to launch in late-2017 NEW YORK & ASTANA, Kazakhstan, May 29, 2017 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq:NDAQ) and Astana International Financial Centre JSC (AIFC) today announced a new, significant agreement. Nasda..

P. Schoenfeld Asset Management LLP : Form 8.3 - Booker Group plc

26/05/2017 15:00:03
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: P. Schoenfeld Asset Management LLP (b) Owner or..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
ANNOUNCEMENT OF A CHANGE IN SHAREHOLDING ACCORDING TO CHAPTER 9, SECTION 10 OF THE FINNISH SECURITIES MARKET ACT
2
ABcann Global and Cannabis Wheaton Sign Interim Agreement for Construction of Additional Cannabis Cultivation Facility
3
German Appeals Court overrules District Court on infringement of SSH patent by Sony but grants a stay pending validity review
4
SAG GEST - SOLUÇÕES AUTOMÓVEL GLOBAIS, SGPS, SA - Consolidated Report Three Months Ended 31 March 2017
5
Astana International Financial Centre JSC and Nasdaq Sign Technology Deal for New AIFC Exchange

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
30 May 2017 06:29:00
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20170517.1 - EUROWEB4 - 2017-05-30 07:29:00 - 2017-05-30 06:29:00 - 1000 - Website: OKAY